Journal of Neuroscience, Vol 14, 5858-5864, Copyright © 1994 by Society for Neuroscience
Opioids inhibit endothelin-mediated DNA synthesis, phosphoinositide turnover, and Ca2+ mobilization in rat C6 glioma cells
J Barg, MM Belcheva, R Zimlichman, R Levy, D Saya, RJ McHale, FE Johnson, CJ Coscia and Z Vogel
Department of Neurobiology, Weizmann Institute of Science, Rehovot, Israel.
Opioid agonists inhibit DNA synthesis in C6 rat glioma cells that express
opioid receptors, induced by desipramine (DMI). This inhibition was not
observed in cells that were not treated with DMI, and thus did not express
opioid-binding sites. Endothelin, a known mitogen, increased thymidine
incorporation dose dependently (up to 1.7-fold) in DMI-treated C6 cells.
This increase was reversed by an anti-idiotypic antibody to opioid
receptors, Ab2AOR, which has opioid agonist properties. The opioid
antagonist naltrexone blocked the inhibition caused by Ab2AOR. Endothelin
also stimulated phosphoinositide (PI) turnover and this effect was
inhibited by morphine (50%) or by Ab2AOR (72%) in DMI-treated but not in
DMI-untreated C6 cells. These actions of morphine and Ab2AOR were reversed
by naltrexone. The inhibition of PI turnover and of thymidine incorporation
by Ab2AOR or morphine was insensitive to pertussis toxin (PTX). Since PI
turnover is known to induce Ca2+ mobilization, it was of interest to
examine the effects of the applied opioids on intracellular Ca2+
concentrations. Endothelin increased the concentration of cytosolic free
Ca2+ in the cells while Ab2AOR, morphine, and beta-endorphin reversed the
endothelin-induced Ca2+ mobilization in DMI-treated but not in
DMI-untreated C6 cells. The effect of these agonists was also blocked by
naltrexone. The results indicate that glial cells can be a target of an
opioid receptor- mediated antimitogenic action and that an abatement in PI
turnover and Ca2+ mobilization may be associated with this mechanism.